Related Experiment Video
Updated: May 31, 2026
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface
Virginia D Winn1, Matthew Gormley, Susan J Fisher
1Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, Colorado 80045.
Insights
Preeclampsia (PE) is a pregnancy disease affecting millions. This study examines placental gene expression to understand PE
Area of Science:
- Obstetrics and Gynecology
- Reproductive Biology
- Genomics
Background:
- Preeclampsia (PE) affects 8 million pregnancies globally, causing significant maternal and neonatal morbidity.
- PE is a two-stage disease initiated by poor placentation, leading to maternal complications in the second half of pregnancy.
- The basal plate of the placenta is implicated in the "poor placentation" characteristic of PE.
Purpose of the Study:
- To investigate the placental contribution to preeclampsia pathogenesis.
- To analyze gene expression profiles of the basal plate in normal and preeclamptic pregnancies.
- To combine existing microarray datasets for a comprehensive view of basal plate pathobiology in PE.
Main Methods:
- Utilized microarray datasets to examine gene expression profiles.
- Compared gene expression in the basal plate between normal and preeclamptic pregnancies.
- Integrated data from multiple microarray studies for enhanced analysis.
Main Results:
- Summarized gene expression profiles from normal and PE placentation datasets.
- Identified gene expression changes in the basal plate associated with PE.
- Provided a combined dataset for a comprehensive view of basal plate pathobiology.
Conclusions:
- Defects in the basal plate are central to preeclampsia development.
- Understanding basal plate pathobiology is crucial for altering PE development and course.
- This research enhances the understanding of PE's placental origins.
Abstract:
Preeclampsia (PE) impacts 8 million mother-infant pairs worldwide each year. This human pregnancy-specific disease characterized by hypertension and proteinuria accounts for significant maternal and neonatal morbidity and mortality. The current theory of the pathogenesis of PE as reviewed by Drs. Christopher Redman and Ian Sargent is thought to occur as a 2-stage process with poor placentation in the first half of pregnancy resulting in the maternal response in the second half of pregnancy. Our studies have focused on understanding the placental contribution to this serious disease by examining the gene expression profile of the deciduas basalis or basal plate, the region of the placenta involved in the "poor placentation". In this review we present summaries of our microarray datasets both of normal placentation and those gene expression changes resulting in the context of PE. Additionally, we have taken this opportunity to combine the data sets to provide a more comprehensive view of this region of the placenta. As defects in the basal plate are, in part, at the root of the disease process, we believe that understanding the pathobiology that occurs in this region will increase our ability to alter the development and/or course of PE.
Related Concept Videos
02:30Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
01:58Cell Specific Gene Expression
01:07Teratogenicity
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...